India, in the world of medicines is a well-known player now. The medicine stalwart has shown its potential during the Corona as well as the post Corona phase.
Now the country has launched first made in India vaccine to defeat the deadly disease called cancer. CERVAAC is going to be the first vaccine against cancer which has been after a prolong efforts finally come up as good news for India and the world.
The first Indian indigenously developed Quadrivalent Human Papillomavirus Vaccine (qHPV) against Cervical cancer was launched by the Union Minister of State Science and Technology yesterday on September 1, 2022.
Again with the CERVAVAC, the Serum Institute of India (SII) along with the Department of Biotechnology (DBT) are in lime light inviting envy from across the world. The Vaccine is also good due to its affordability for all costing around 200 to 400 rupees per dose.
Going by the data of the government, cervical cancer is among the most prevalent cancer type in India accounting for around twenty five per cent of the world’s cervical cancer demises.
Lakhs of Indian women are diagnosed with Cervical cancer and out of them around 70 to 80 per cent die from it. Modi government now is now planning to start vaccination campaign for the girl child against cervical cancer aging from the age of 9 to 14 years.